• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

国际骨质疏松基金会/国际临床骨密度学会亚太地区 FRAX 倡议官方立场共识。

Consensus of official position of IOF/ISCD FRAX initiatives in Asia-Pacific region.

机构信息

Department of Family Medicine, National Cheng Kung University Hospital and College of Medicine, Tainan, Taiwan.

Academic Unit of Bone Metabolism, University of Sheffield, Sheffield, UK.

出版信息

J Clin Densitom. 2014 Jan-Mar;17(1):150-5. doi: 10.1016/j.jocd.2013.06.002. Epub 2013 Jul 31.

DOI:10.1016/j.jocd.2013.06.002
PMID:
23916756
Abstract

The fracture risk assessment tool (FRAX(®)) has been developed for the identification of individuals with high risk of fracture in whom treatment to prevent fractures would be appropriate. FRAX models are not yet available for all countries or ethnicities, but surrogate models can be used within regions with similar fracture risk. The International Society for Clinical Densitometry (ISCD) and International Osteoporosis Foundation (IOF) are nonprofit multidisciplinary international professional organizations. Their visions are to advance the awareness, education, prevention, and treatment of osteoporosis. In November 2010, the IOF/ISCD FRAX initiative was held in Bucharest, bringing together international experts to review and create evidence-based official positions guiding clinicians for the practical use of FRAX. A consensus meeting of the Asia-Pacific (AP) Panel of the ISCD recently reviewed the most current Official Positions of the Joint Official Positions of ISCD and IOF on FRAX in view of the different population characteristics and health standards in the AP regions. The reviewed position statements included not only the key spectrum of positions but also unique concerns in AP regions.

摘要

骨折风险评估工具(FRAX(®))是为识别骨折风险高的个体而开发的,这些个体需要进行治疗以预防骨折。并非所有国家或种族都有 FRAX 模型,但在骨折风险相似的地区可以使用替代模型。国际临床密度测定学会(ISCD)和国际骨质疏松基金会(IOF)是非营利性多学科国际专业组织。它们的愿景是提高对骨质疏松症的认识、教育、预防和治疗。2010 年 11 月,IOF/ISCD FRAX 倡议在布加勒斯特举行,汇集了国际专家,对 FRAX 的实际应用进行了基于证据的审查,并制定了官方立场指导临床医生。ISCD 亚太地区小组最近举行了一次共识会议,审议了 ISCD 和 IOF 联合 FRAX 官方立场的最新官方立场,考虑到亚太地区的不同人口特征和健康标准。审议的立场声明不仅包括关键立场范围,还包括亚太地区的独特关注点。

相似文献

1
Consensus of official position of IOF/ISCD FRAX initiatives in Asia-Pacific region.国际骨质疏松基金会/国际临床骨密度学会亚太地区 FRAX 倡议官方立场共识。
J Clin Densitom. 2014 Jan-Mar;17(1):150-5. doi: 10.1016/j.jocd.2013.06.002. Epub 2013 Jul 31.
2
International Society for Clinical Densitometry official positions: Asia-Pacific Region consensus.国际临床密度测定学会官方立场:亚太地区共识。
J Clin Densitom. 2010 Oct-Dec;13(4):346-51. doi: 10.1016/j.jocd.2010.05.006. Epub 2010 Jul 21.
3
Joint Official Positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(®). Executive Summary of the 2010 Position Development Conference on Interpretation and use of FRAX® in clinical practice.国际临床密度测定学会和国际骨质疏松基金会关于 FRAX(®)的联合官方立场。2010 年 FRAX®临床实践解释和应用立场发展会议执行摘要。
J Clin Densitom. 2011 Jul-Sep;14(3):171-80. doi: 10.1016/j.jocd.2011.05.007.
4
FRAX(®) Bone Mineral Density Task Force of the 2010 Joint International Society for Clinical Densitometry & International Osteoporosis Foundation Position Development Conference.2010 年国际临床骨密度学会与国际骨质疏松基金会联合专题工作组:FRAX(®)骨密度。
J Clin Densitom. 2011 Jul-Sep;14(3):223-5. doi: 10.1016/j.jocd.2011.05.018.
5
Official Positions for FRAX® Bone Mineral Density and FRAX® simplification from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®.FRAX® 骨密度和 FRAX® 简化的官方立场,来自国际临床密度测定学会和国际骨质疏松基金会关于 FRAX® 的联合官方立场发展会议。
J Clin Densitom. 2011 Jul-Sep;14(3):226-36. doi: 10.1016/j.jocd.2011.05.017.
6
FRAX(®) Clinical Task Force of the 2010 Joint International Society for Clinical Densitometry & International Osteoporosis Foundation Position Development Conference.国际临床骨密度学会与国际骨质疏松基金会 2010 年联合临床专题工作组 FRAX(®)立场声明
J Clin Densitom. 2011 Jul-Sep;14(3):181-3. doi: 10.1016/j.jocd.2011.05.013.
7
Official Positions for FRAX® clinical regarding international differences from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®.FRAX®临床官方立场——关于国际临床骨密度学会和国际骨质疏松基金会联合官方立场对 FRAX®的国际差异
J Clin Densitom. 2011 Jul-Sep;14(3):240-62. doi: 10.1016/j.jocd.2011.05.015.
8
FRAX® International Task Force of the 2010 Joint International Society for Clinical Densitometry & International Osteoporosis Foundation Position Development Conference.国际临床骨密度学会和国际骨质疏松基金会 2010 年联合专题工作组 FRAX®国际任务组立场发布会。
J Clin Densitom. 2011 Jul-Sep;14(3):237-9. doi: 10.1016/j.jocd.2011.05.016.
9
Interpretation and use of FRAX in clinical practice.FRAX 在临床实践中的解读和应用。
Osteoporos Int. 2011 Sep;22(9):2395-411. doi: 10.1007/s00198-011-1713-z. Epub 2011 Jul 21.
10
Official Positions for FRAX(®) clinical regarding glucocorticoids: the impact of the use of glucocorticoids on the estimate by FRAX(®) of the 10 year risk of fracture from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(®).FRAX(®)临床关于糖皮质激素的官方立场:糖皮质激素的使用对 FRAX(®)评估 10 年骨折风险的影响——国际临床骨密度学会和国际骨质疏松基金会关于 FRAX(®)的联合官方立场发展会议。
J Clin Densitom. 2011 Jul-Sep;14(3):212-9. doi: 10.1016/j.jocd.2011.05.014.

引用本文的文献

1
Machine learning models to predict osteoporosis in patients with chronic kidney disease stage 3-5 and end-stage kidney disease.用于预测慢性肾脏病3-5期及终末期肾病患者骨质疏松症的机器学习模型。
Sci Rep. 2025 Apr 3;15(1):11391. doi: 10.1038/s41598-025-95928-5.
2
A cross-sectional study comparing machine learning and logistic regression techniques for predicting osteoporosis in a group at high risk of cardiovascular disease among old adults.一项横断面研究,比较机器学习和逻辑回归技术在预测老年人心血管疾病高危人群骨质疏松症中的应用。
BMC Geriatr. 2025 Mar 29;25(1):209. doi: 10.1186/s12877-025-05840-w.
3
Impact of patient education by nurse case managers on decision making for out-of-pocket anti-osteoporotic pharmaceutical therapy: a single-center retrospective study.
护士个案管理者开展的患者教育对骨质疏松症自费药物治疗决策的影响:一项单中心回顾性研究。
BMC Nurs. 2024 Nov 6;23(1):808. doi: 10.1186/s12912-024-02467-x.
4
Decomposing and simplifying the Fracture Risk Assessment Tool-a module from the Taiwan-specific calculator.分解并简化骨折风险评估工具——台湾地区特定计算器中的一个模块。
JBMR Plus. 2024 Mar 23;8(5):ziae039. doi: 10.1093/jbmrpl/ziae039. eCollection 2024 May.
5
Clinical application of the fracture risk assessment tool in the general population and its correlation with bone turnover markers.骨折风险评估工具在普通人群中的临床应用及其与骨转换标志物的相关性。
Front Pharmacol. 2023 Jan 10;13:1013483. doi: 10.3389/fphar.2022.1013483. eCollection 2022.
6
Validation of the Taiwan FRAX® calculator for the prediction of fracture risk.验证台湾 FRAX®计算器预测骨折风险的能力。
Arch Osteoporos. 2022 Jan 29;17(1):27. doi: 10.1007/s11657-022-01068-y.
7
The diversity of Fracture Risk Assessment Tool (FRAX)-based intervention thresholds in Asia.亚洲基于骨折风险评估工具(FRAX)的干预阈值的多样性。
Osteoporos Sarcopenia. 2019 Dec;5(4):104-108. doi: 10.1016/j.afos.2019.12.002. Epub 2019 Dec 16.
8
Budget impact analysis of osteoporosis medications for primary prevention of fractures in Taiwan.台湾骨质疏松症药物用于骨折初级预防的预算影响分析。
J Bone Miner Metab. 2020 May;38(3):316-327. doi: 10.1007/s00774-019-01061-5. Epub 2019 Nov 11.
9
Temporal changes in access to FRAX® in Thailand between 2010 and 2018.2010 年至 2018 年期间,泰国 FRAX® 可及性的时间变化。
Arch Osteoporos. 2019 Jun 21;14(1):66. doi: 10.1007/s11657-019-0613-2.
10
The differences in the relationship between obstructive sleep apnea severity and trabecular bone score in men and women with type 2 diabetes.2型糖尿病男性和女性中阻塞性睡眠呼吸暂停严重程度与小梁骨评分之间关系的差异。
J Clin Transl Endocrinol. 2019 May 2;16:100193. doi: 10.1016/j.jcte.2019.100193. eCollection 2019 Jun.